Mammography-based screening program: preliminary results from a first 2-year round in a Brazilian region using mobile and fixed units

Carregando...
Imagem de Miniatura
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
HAIKEL JR., Raphael Luiz
MAUAD, Edmundo Carvalho
SILVA, Thiago Buosi
MATTOS, Jaco Saraiva de Castro
CHALA, Luciano Fernandes
Citação
BMC WOMENS HEALTH, v.12, article ID 32, 7p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer deaths among women worldwide. The use of mobile mammography units to offer screening to women living in remote areas is a rational strategy to increase the number of women examined. This study aimed to evaluate results from the first 2 years of a government-organized mammography screening program implemented with a mobile unit (MU) and a fixed unit (FU) in a rural county in Brazil. The program offered breast cancer screening to women living in Barretos and the surrounding area. Methods: Based on epidemiologic data, 54 238 women, aged 40 to 69 years, were eligible for breast cancer screening. The study included women examined from April 1, 2003 to March 31, 2005. The chi-square test and Bonferroni correction analyses were used to evaluate the frequencies of tumors and the importance of clinical parameters and tumor characteristics. Significance was set at p < 0.05. Results: Overall, 17 964 women underwent mammography. This represented 33.1% of eligible women in the area. A mean of 18.6 and 26.3 women per day were examined in the FU and MU, respectively. Seventy six patients were diagnosed with breast cancer (41 (54%) in the MU). This represented 4.2 cases of breast cancer per 1000 examinations. The number of cancers detected was significantly higher in women aged 60 to 69 years than in those aged 50 to 59 years (p < 0.001) or 40 to 49 years (p < 0.001). No difference was observed between women aged 40 to 49 years and those aged 50 to 59 years (p = 0.164). The proportion of tumors in the early (EC 0 and EC I) and advanced (CS III and CS IV) stages of development were 43.4% and 15.8%, respectively. Conclusions: Preliminary results indicate that this mammography screening program is feasible for implementation in a rural Brazilian territory and favor program continuation.
Palavras-chave
Cancer screening, Cancer prevention, Mammogram
Referências
  1. Alexy BB, 1998, PUBLIC HEALTH NURS, V15, P3, DOI 10.1111/j.1525-1446.1998.tb00314.x
  2. Ascunce N, 1994, Eur J Cancer Prev, V3 Suppl 1, P41, DOI 10.1097/00008469-199401001-00007
  3. Autier P, 2002, INT J CANCER, V97, P828, DOI 10.1002/ijc.10161
  4. Biesheuvel C, 2011, BREAST CARE, V6, P104, DOI 10.1159/000327493
  5. Brasil. Ministerio da Saude. Instituto Nacional de Cancer Jose A.lencar Gomes da Silva (INCA), 2011, EST 2012 INC CANC BR
  6. BROWN ML, 1995, RADIOLOGY, V195, P529
  7. Bulliard JL, 2004, BREAST, V13, P284, DOI 10.1016/j.breast.2004.03.001
  8. Bulliard JL, 2004, J MED SCREEN, V11, P59, DOI 10.1258/096914104774061029
  9. Chamot E, 2009, J EVAL CLIN PRACT, V15, P620, DOI 10.1111/j.1365-2753.2008.01062.x
  10. Commission E, 2006, EUR GUID QUAL ASS BR
  11. DERSHAW DD, 1992, RADIOLOGY, V184, P415
  12. Duffy SW, 2002, CANCER, V95, P458, DOI 10.1002/cncr.10765
  13. Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245
  14. Frelix GD, 1999, J NATL MED ASSOC, V91, P195
  15. Health Canada, 2003, BOOK QUAL DET ORG BR, P95
  16. Humphrey LL, 2002, ANN INTERN MED, V137, P347
  17. Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
  18. Lacour A., 1997, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V26, P470
  19. Levin JR, 1997, J AM GERIATR SOC, V45, P1365
  20. LIDBRINK E, 1995, BREAST CANCER RES TR, V35, P267, DOI 10.1007/BF00665978
  21. LIDBRINK EK, 1994, ACTA ONCOL, V33, P353
  22. Mauad EC, 2011, J MED SCREEN, V18, P51, DOI 10.1258/jms.2011.010124
  23. Mauad EC, 2009, RURAL REMOTE HEALTH, V9
  24. McElroy Jane A, 2006, Prev Chronic Dis, V3, pA10
  25. Meissner HI, 2011, CANCER-AM CANCER SOC, V117, P3101, DOI 10.1002/cncr.25873
  26. National Evaluation Team for Breast cancer screening in the Netherlands (NETB), 2011, BOOK NETB INT REP 20
  27. Njor SH, 2003, APMIS S, V110, P1
  28. NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V
  29. Olivotto IA, 1999, BREAST CANCER RES TR, V54, P73, DOI 10.1023/A:1006152918283
  30. Paquette D, 2000, CAN MED ASSOC J, V163, P1133
  31. Parkin DM, 2005, CA-CANCER J CLIN, V55, P74
  32. Pollan M, 2010, ANN ONCOL, V21, piii97
  33. Reding D J, 1997, Wis Med J, V96, P32
  34. Sarkeala T, 2004, EUR J CANCER, V40, P2116, DOI 10.1016/j.ejca.2004.06.017
  35. Sasieni P, 2003, ANN ONCOL, V14, P1206, DOI 10.1093/annonc/mdg325
  36. Schouten LJ, 1998, J MED SCREEN, V5, P37
  37. SEGURET F, 1995, EUR J CANCER PREV, V4, P299
  38. Smith RA, 2011, SALUD PUBLICA MEXICO, V53, P394
  39. Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129
  40. Stamenic V, 2011, CROAT MED J, V52, P76, DOI 10.3325/cmj.2011.52.76
  41. Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3
  42. Vejborg I, 2002, J MED SCREEN, V9, P115, DOI 10.1136/jms.9.3.115
  43. Vizcaino I, 1998, RADIOLOGY, V206, P253
  44. Wait S, 1997, B CANCER, V84, P619